Results 81 to 90 of about 751,968 (244)

Factors Affecting Late Introduction of Complementary Food: A Kaplan Meier Analysis

open access: yesNational Journal of Community Medicine, 2014
Introduction: Late introduction of complementary food is associated with malnutrition and in India about 47% of children are given complementary food at age ≥6 months.
V M Holambe, N A Thakur
doaj  

Incidence and risk factors of surgical site infection following cesarean section: a prospective cohort study at Jimma university medical center

open access: yesBMC Infectious Diseases
Background Surgical site infection (SSI) after cesarean section (CS) is one of the contributors for high maternal mortality and morbidity rates. Aim This prospective cohort analysis assessed the incidence rate and risk factors of time to SSI following CS
Etagegn Shacho   +3 more
doaj   +1 more source

Kaplan-Meier survival curves.

open access: yes, 2018
Kaplan-Meier curves for (A) metastasis-free and (B) overall survivals in the bone and soft tissue post-radiation sarcomas.
June Hyuk Kim (5866568)   +10 more
core   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Kaplan-Meier survival estimate of transfused patients.

open access: yes, 2022
Kaplan-Meier survival estimate of transfused patients.
Bridget Angucia (13844289)   +6 more
core   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Survival analysis of A.C. machines in the diamond industry using the Kaplan-Meier estimator

open access: yesMATEC Web of Conferences, 2017
The article deals with the survival analysis of a.c. machines operating under the conditions of the underground mine “Mir” (Yakutia). The estimation of their survival is carried out using the Kaplan-Meier estimator.
Shevchuk Vladislav A.   +2 more
doaj   +1 more source

Kaplan-Meier graph.

open access: yes, 2018
Kaplan-Meier graph visualizing the proportion of injury-free runners as a function of follow-up time. The results revealed 32% [95% CI: 26; 37] of the runners sustained injury over the 24 weeks.
Rasmus Oestergaard Nielsen (577401)   +3 more
core   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

Kaplan-Meier mortality curves.

open access: yes, 2018
Kaplan-Meier graphs showing failure function for risk experienced before and after January 1st, 2007. Shaded areas indicate 95% confidence intervals. The curves are significantly different in both analyses (under-one: p = 0.007; under-five: p < 0.001).
Troy D. Moon (503477)   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy